Safety of treating myelofibrosis with ruxolitinib – results from JUMP trial
Haifa Kathrin Al-Ali
Second-line myelofibrosis treatment – the potential of JAK2 inhibitor NS-018
What's new in myeloproliferative neoplasms?
Naveen Pemmaraju: what to look out for at ASH 2016
How can pregnancy in myeloproliferative neoplasms (MPNs) be managed?